SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001019056-15-000826
Filing Date
2015-10-22
Accepted
2015-10-22 11:49:19
Documents
2
Period of Report
2015-10-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT aldeyra_3.html 3  
1 OWNERSHIP DOCUMENT aldeyra_3.xml 3 5521
2 EXHIBIT 24 ex_24.htm EX-24 7256
  Complete submission text file 0001019056-15-000826.txt   15543
Mailing Address PERCEPTIVE ADVISORS LLC 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
EDELMAN JOSEPH (Reporting) CIK: 0001164426 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36332 | Film No.: 151169554

Mailing Address 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 646-205-5340
PERCEPTIVE ADVISORS LLC (Reporting) CIK: 0001224962 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36332 | Film No.: 151169556

Mailing Address C/O PERCEPTIVE ADVISORS LLC 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address C/O PERCEPTIVE ADVISORS LLC 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 646-205-5340
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting) CIK: 0001249675 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36332 | Film No.: 151169555

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Issuer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations